These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 325824)

  • 1. Enhancement of heart allograft survival across H-2 complex.
    Davis WC
    Transplant Proc; 1977 Mar; 9(1):937-9. PubMed ID: 325824
    [No Abstract]   [Full Text] [Related]  

  • 2. Active enhancement of donor-strain skin in mice bearing H-2D-incompatible heart allografts.
    Corry RJ; Kelley SE
    Transplant Proc; 1977 Mar; 9(1):945-9. PubMed ID: 325825
    [No Abstract]   [Full Text] [Related]  

  • 3. Both L- and D-isomers of allotrap 2702 prolong cardiac allograft survival in mice.
    Gao L; Woo J; Buelow R
    J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):78-87. PubMed ID: 8820086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of immunologic enhancement in rats by use of antigen-antibody complexes.
    Marquet RL; Heystek GA; van Leersum RH
    Transplant Proc; 1977 Mar; 9(1):949-51. PubMed ID: 325826
    [No Abstract]   [Full Text] [Related]  

  • 5. Dose-dependent effect of intrathymically injected 3-mol/L KCl-extracted histocompatibility antigens to prolong heart allograft survival in rats.
    Hamashima T; Stepkowski SM; Kahan BD
    Transplant Proc; 1995 Feb; 27(1):134-5. PubMed ID: 7878904
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of monoclonal antibody on corneal graft survival across major and minor histocompatibility mismatches.
    Duguid IG; Koulmanda M; Mandel TE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):844. PubMed ID: 8438499
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful enhancement of canine renal allografts.
    Martin DC
    Invest Urol; 1973 Sep; 11(2):165-9. PubMed ID: 4580546
    [No Abstract]   [Full Text] [Related]  

  • 8. Class I antigen pretreatment prolongs allograft survival in mice by induction of suppressor cells.
    Superina RA; Wood KJ; Morris PJ
    Transplant Proc; 1987 Aug; 19(4):3459-60. PubMed ID: 2956744
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of pretreatment with class I major histocompatibility complex (MHC) antigens on hepatic or cardiac allograft survival in the rat.
    Yamaguchi Y; Harland RC; Wyble C; Bollinger RR
    Transplant Proc; 1989 Jun; 21(3):3555. PubMed ID: 2662527
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of M-locus (non-H-2) and K-end and D-end (H-2-region) incompatibility on heart muscle allograft survival time.
    Huber B; Démant P; Festenstein H
    Transplant Proc; 1973 Dec; 5(4):1377-83. PubMed ID: 4590620
    [No Abstract]   [Full Text] [Related]  

  • 11. Spontaneous long-term survival of liver allograft in inbred rats.
    Houssin D; Gigou M; Franco D; Szekely AM; Bismuth H
    Transplant Proc; 1979 Mar; 11(1):567-70. PubMed ID: 377695
    [No Abstract]   [Full Text] [Related]  

  • 12. Synergistic effect of 3M KCl-extracted donor antigens with cyclosporine or cyclosporine/rapamycin to prolong heart allograft survival in rats.
    Hamashima T; Stepkowski SM; Smith S; Kahan BD
    Transplant Proc; 1994 Oct; 26(5):3053-5. PubMed ID: 7940960
    [No Abstract]   [Full Text] [Related]  

  • 13. Interleukin-10 eliminates anti-CD3 monoclonal antibody-induced mortality and prolongs heart allograft survival in inbred mice.
    Lowry RP; Konieczny B; Alexander D; Larsen C; Pearson T; Smith S; Narula S
    Transplant Proc; 1995 Feb; 27(1):392-4. PubMed ID: 7879034
    [No Abstract]   [Full Text] [Related]  

  • 14. Transfusion-induced skin allograft enhancement across an H-2 class-I mismatch is caused by a clonal deletion of donor-specific cytotoxic T-lymphocyte precursors within the allograft.
    van Twuyver E; Kast WM; Mooijaart RJ; Melief CJ; de Waal LP
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1169-70. PubMed ID: 2650087
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of individual minor histocompatibility antigens in cardiac allograft rejection.
    Peugh WN; Wood KJ; Shreffler DC; Morris PJ; Morton-Bolman R
    Transplant Proc; 1989 Feb; 21(1 Pt 1):801-2. PubMed ID: 2650274
    [No Abstract]   [Full Text] [Related]  

  • 16. Murine cardiac allograft survival following treatment of recipients with monoclonal anti-L3T4 or Ly-2 antibodies.
    Mottram PL; Wheelahan J; McKenzie IF; Clunie GJ
    Transplant Proc; 1987 Apr; 19(2):2898-901. PubMed ID: 3105127
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of a combined heart and carotid artery transplant model to investigate the impact of acute rejection on cardiac allograft vasculopathy.
    Soleimani B; Fu F; Lake P; Shi VC
    J Heart Lung Transplant; 2008 Apr; 27(4):450-6. PubMed ID: 18374883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathymic injection of anti-Fas monoclonal antibody prolongs murine non-vascularized cardiac allograft survival.
    Djamali A; Waller KR; McAnulty J; Hullett D; Becker BN; Odorico JS
    Transpl Int; 2004 Jul; 17(6):301-9. PubMed ID: 15205723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of antiidiotypic antibodies in the rat: in vitro characterization of specificity and correlation with in vivo specific suppression of cardiac allograft immune reaction across major histocompatibility complex.
    Wasfie T; Reed E; Suciu-Foca N; Hardy MA
    Surgery; 1990 Aug; 108(2):431-40; discussion 440-1. PubMed ID: 2143319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elimination of OX8+ cells prolongs cardiac but not pancreatic allograft survival across minor (non-MHC) histocompatibility barriers.
    Roza AM; Johnson CP; Adams MB; Naji A
    Transplant Proc; 1990 Apr; 22(2):747-8. PubMed ID: 2327028
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.